Please use this identifier to cite or link to this item:
|Title:||Biomarkers in Pulmonary Arterial Hypertension|
|Authors:||SOUZA, Rogerio; HOETTE, Susana; DIAS, Bruno; JARDIM, Carlos|
|Citation:||Biomarkers in Pulmonary Arterial Hypertension. In: Humbert, M; Souza, R; Simonneau, G (eds). PULMONARY VASCULAR DISORDERS, v.41. BASEL: KARGER, 2012. p.59-64. (Progress in Respiratory Research)|
|Abstract:||Together with the improvement of pulmonary arterial hypertension (PAH) management arises the need for adequate surrogate markers for treatment decision and follow-up. In this setting, biomarkers play a definitive role. A number of biomarkers addressing specific features of the different pathophysiological mechanisms of PAH, with the ability to describe disease severity and prognosis, have been described. This chapter reviews the characteristics of the different existing biomarkers as the rationale for their integration as the next step for the evaluation of PAH patients. Copyright (C) 2012 S. Karger AG, Basel|
|Appears in Collections:||Livros e Capítulos de Livros - FM/MCP|
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - HC/InCor
Livros e Capítulos de Livros - LIM/09
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.